Alliance Resource Partners reported a strong Q3 with revenue up 5.5% and EPS rising 47.9% year-over-year, driven by improved coal segment margins and record Illinois Basin production despite lower prices. The company’s distribution coverage ratio increased to 1.76x, leverage remains low at 0.89x, and it offers a high yield of 9.04%. Trading at a low EV/EBITDA multiple of 5.87x compared to peers, ARLP's forward sales and export commitments support confidence in future distributions, justifying the maintained Buy rating.
Alliance Resource's strong distribution coverage ratio of 1.76x provides key context for readers. For those following the energy sector, here is Pluang's market snapshot as of Oct 29, 2026 19:13 WIB: Among 79 priced US energy stocks, 53 rose and 25 fell today. Notable movers include Shell PLC (SHEL) up 4.14% at USD 109.55 with a typical hold time of 92 days and a Pluang order activity split of 40% Sell / 60% Buy, Cheniere Energy (LNG) up 4.11% at USD 310.00 with a 99% Sell order activity, and Antero Resources Corporation (AR) down 4.03% at USD 40.46 with 100% Sell order activity and a typical hold time of 6 days.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
